BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29911367)

  • 1. [Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters].
    Zhou Q; Yu LS; Zeng S
    Yao Xue Xue Bao; 2017 Jan; 52(1):1-7. PubMed ID: 29911367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
    Ahmed S; Zhou Z; Zhou J; Chen SQ
    Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics: Driving Personalized Medicine.
    Sadee W; Wang D; Hartmann K; Toland AE
    Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics and systems biology of membrane transporters.
    Yan Q
    Mol Biotechnol; 2005 Jan; 29(1):75-88. PubMed ID: 15668521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized medicine: going to the dogs?
    Mealey KL; Martinez SE; Villarino NF; Court MH
    Hum Genet; 2019 May; 138(5):467-481. PubMed ID: 31032534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications.
    Yiannakopoulou ECh
    Pharmacogenomics J; 2013 Apr; 13(2):105-9. PubMed ID: 23044602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DMETâ„¢ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
    Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy.
    Li J; Bluth MH
    Pharmgenomics Pers Med; 2011; 4():11-33. PubMed ID: 23226051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine.
    Hassan R; Allali I; Agamah FE; Elsheikh SSM; Thomford NE; Dandara C; Chimusa ER
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33253350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane transporters and drug development: relevance to pharmacogenomics, nutrigenomics, epigenetics, and systems biology.
    Yan Q
    Methods Mol Biol; 2010; 637():1-21. PubMed ID: 20419427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward.
    Lauschke VM; Zhou Y; Ingelman-Sundberg M
    Annu Rev Pharmacol Toxicol; 2024 Jan; 64():33-51. PubMed ID: 37506333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.
    Brian W; Tremaine LM; Arefayene M; de Kanter R; Evers R; Guo Y; Kalabus J; Lin W; Loi CM; Xiao G
    Pharmacogenomics; 2016 Apr; 17(6):615-31. PubMed ID: 27045656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.
    Stanke-Labesque F; Gautier-Veyret E; Chhun S; Guilhaumou R;
    Pharmacol Ther; 2020 Nov; 215():107627. PubMed ID: 32659304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective.
    Rao T; Tan Z; Peng J; Guo Y; Chen Y; Zhou H; Ouyang D
    Pharmacol Res; 2019 Aug; 146():104283. PubMed ID: 31129178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in pharmacogenetics and pharmacogenomics.
    Vesell ES
    J Clin Pharmacol; 2000 Sep; 40(9):930-8. PubMed ID: 10975065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics for the forensic toxicologist.
    Kupiec TC; Raj V; Vu N
    J Anal Toxicol; 2006 Mar; 30(2):65-72. PubMed ID: 16620540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating pharmacogenomics into personalized medicine and drug development.
    Zhang W; Chan TY; Fan L; Guo Y; Zhou HH
    Per Med; 2012 Jan; 9(1):93-97. PubMed ID: 29783288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
    Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
    Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.